1-17 of 17
Thomas Dejoie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal Residual Disease Monitoring By Targeted Mass Spectrometry Allows Early Relapse Detection in Multiple Myeloma

Somayya Noori, Charissa Wijnands, Pieter Langerhorst, Simon Nadal, Vincent Bonifay, Christoph Stingl, Cyrille Touzeau, Theo Luider, Thomas Dejoie, Johannes Jacobs, Martijn Vanduijn
Journal: Blood
Blood (2022) 140 (Supplement 1): 2349–2350.
https://doi.org/10.1182/blood-2022-156898
Published: 2022
Journal Articles

Minimal Residual Disease in Multiple Myeloma: Targeted Mass Spectrometry in Blood Vs Next Generation Sequencing in Bone Marrow

Marina Zajec, Pieter Langerhorst, Somayya Noori, Martijn van Duijn, Yolanda de Rijke, Jolein Gloerich, Alain van Gool, Jill Corre, PharmD, PhD, Thomas Dejoie, Helene Caillon, Joannes Jacobs, Theo Luider, Herve Avet-Loiseau
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-139330
Published: 2020
Journal Articles

Absence of Influence of the Pre-Transplant Immune Status of Recipients on Survivals and Gvhd after Allogeneic Stem Cell Transplantation: A Retrospective Study of 195 Cases

Baptiste Le Calvez, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Amandine Le Bourgeois, MD, Marie Audrain, MD PhD, Marion Eveillard, Thomas Dejoie, Béatrice Mahé, MD, Viviane Dubruille, Nicolas Blin, MD, Cyrille Touzeau, Thomas Gastinne, MD, Anne Lok, Benoit Tessoulin, MD PhD, Sophie Vantyghem, Steven Le Gouill, MD PhD, Philippe Moreau, MD, Marie C Bene, PharmSci, PhD, Patrice Chevalier, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-136743
Published: 2020
Journal Articles

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Clinical Trials & Observations
Aurore Perrot, Valerie Lauwers-Cances, Jill Corre, Nelly Robillard, Cyrille Hulin, Marie-Lorraine Chretien, Thomas Dejoie, Sabrina Maheo, Anne-Marie Stoppa, Brigitte Pegourie, Lionel Karlin, Laurent Garderet, Bertrand Arnulf, Chantal Doyen, Nathalie Meuleman, Bruno Royer, Jean-Richard Eveillard, Lotfi Benboubker, Mamoun Dib, Olivier Decaux, Arnaud Jaccard, Karim Belhadj, Sabine Brechignac, Brigitte Kolb, Cecile Fohrer, Mohamad Mohty, Margaret Macro, Paul G. Richardson, Victoria Carlton, Martin Moorhead, Tom Willis, Malek Faham, Kenneth C. Anderson, Jean-Luc Harousseau, Xavier Leleu, Thierry Facon, Philippe Moreau, Michel Attal, Hervé Avet-Loiseau, Nikhil Munshi
Journal: Blood
Blood (2018) 132 (23): 2456–2464.
https://doi.org/10.1182/blood-2018-06-858613
Published: 2018
Includes: Supplemental data
Journal Articles

Light Chain Escape in Multiple Myeloma

Thomas Dejoie, MD, Guillemette Fouquet, Cyrille Hulin, Murielle Roussel, Benjamin Hebraud, Lionel Karlin, MD, Brigitte Kolb, MD, Carla Araujo, MD, Nathalie Meuleman, PhD MD, Mourad Tiab, MD, Jean Valère Malfuson, MD, Pascal Bourquard, MD, Pascal Lenain, MD, Arnaud Jaccard, MD PhD, Karim Belhadj, Gérard Lepeu, MD, Marie Lorraine Chretien, MD, Denis Caillot, Jean Fontan, MD, Philippe Rodon, MD, Anna Schmitt, Laurent Voillat, MD, Sophie Cereja, MD, Brigitte Pegourie, MD, Frederique Kuhnowski, MD, Sophie Rigaudeau, MD, Olivier Decaux, MD, Catherine Humbrecht-Kraut, MD, Jamilé Frayfer, MD, Laurent Garderet, Damien Roos-Weil, MD, Jean Claude Eisenmann, MD, Veronique Dorvaux, MD, Eric G. Voog, MD, Claire Mathiot, MD, Jean-Paul Fermand, MD, Thierry Facon, Hervé Avet-Loiseau, MD PhD, Jean Luc Harousseau, MD, Philippe Moreau, Michel Attal, MD PhD, Xavier Leleu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1881.
https://doi.org/10.1182/blood-2018-99-112396
Published: 2018
Journal Articles

Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination before and after Autologous Stem Cell Transplantation (ASCT) Followed By Ixazomib Maintenance Is a Safe and Effective Strategy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du MyéLome (IFM)

Philippe Moreau, MDPhD, Cyrille Hulin, MD, Denis Caillot, MD, Gerald Marit, MD, Aurore Perrot, MD, Laurent Garderet, MD PhD, Thierry Facon, MD, Lofti Benboubker, MD, Lionel Karlin, MD, Mourad Tiab, Bertrand Arnulf, MD PhD, Xavier Leleu, MD PhD, Cyrille Touzeau, MD PhD, Murielle Roussel, Lucie Planche, Hervé Avet-Loiseau, Thomas Dejoie, Michel Attal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2021.
https://doi.org/10.1182/blood.V130.Suppl_1.2021.2021
Published: 2017
Journal Articles

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma

CME
Thomas Dejoie, Jill Corre, Helene Caillon, Cyrille Hulin, Aurore Perrot, Denis Caillot, Eileen Boyle, Marie-Lorraine Chretien, Jean Fontan, Karim Belhadj, Sabine Brechignac, Olivier Decaux, Laurent Voillat, Philippe Rodon, Olivier Fitoussi, Carla Araujo, Lotfi Benboubker, Charlotte Fontan, Mourad Tiab, Pascal Godmer, Odile Luycx, Olivier Allangba, Jean-Michel Pignon, Jean-Gabriel Fuzibet, Laurence Legros, Anne Marie Stoppa, Mamoun Dib, Brigitte Pegourie, Frederique Orsini-Piocelle, Lionel Karlin, Bertrand Arnulf, Murielle Roussel, Laurent Garderet, Mohamad Mohty, Nathalie Meuleman, Chantal Doyen, Pascal Lenain, Margaret Macro, Xavier Leleu, Thierry Facon, Philippe Moreau, Michel Attal, Herve Avet-Loiseau
Journal: Blood
Blood (2016) 128 (25): 2941–2948.
https://doi.org/10.1182/blood-2016-07-726778
Published: 2016
Journal Articles

Responses Assigned Using Heavy+Light Chain Assessments Have Better Clinical Correlation with Outcome Than Those Using Current IMWG Criteria for Multiple Myeloma

Mauricette Michallet, MD PhD, Colette Chapuis-Cellier, Dr, Christine Lombard, Dr, Mohamad Sobh, PharmD, Thomas Dejoie, PharmD, Helene Caillon, PharmD, Michel Attal, Philippe Moreau, Herve Avet-Loiseau, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3245.
https://doi.org/10.1182/blood.V128.22.3245.3245
Published: 2016
Journal Articles

Serum Free Light Chain Responses Have Greater Concordance with Clinical Outcomes Than Those Assessed By Urine Electrophoresis in Light Chain Multiple Myeloma Patients

Thomas Dejoie, PharmD, Michel Attal, Philippe Moreau, Herve Avet-Loiseau, MD PhD
Journal: Blood
Blood (2016) 128 (22): 376.
https://doi.org/10.1182/blood.V128.22.376.376
Published: 2016
Journal Articles

Overcoming the Interference of Daratumumab with Immunofixation Electrophoresis (IFE) Using an Industry-Developed Dira Test : Hydrashift 2/4 Daratumumab

Helene Caillon, PharmD, Alix Irimia, Residential student, Jason S. Simon, PhD, Amy Axel, Kate Sasser, Matthew James Scullion, PhD BSc, Thierry Ligneel, PhD, Georges Nouadje, PhD, Philippe Moreau, Thomas Dejoie, PharmD
Journal: Blood
Blood (2016) 128 (22): 2063.
https://doi.org/10.1182/blood.V128.22.2063.2063
Published: 2016
Journal Articles

Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination before and after Autologous Stem Cell Transplantation (ASCT) Followed By Ixazomib Maintenance in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du MyéLome (IFM)

Philippe Moreau, MD, Cyrille Hulin, MD, Denis Caillot, Gerald Marit, MD, Aurore Perrot, MD, Laurent Garderet, MD, Thierry Facon, MD, Lotfi Benboubker, MD PhD, Lionel Karlin, MD, Mourad Tiab, Bertrand Arnulf, MD, Jean-Paul Fermand, Xavier Leleu, Cyrille Touzeau, MD, Murielle Roussel, MD, Lucie Planche, Stephane Minvielle, Marie-Christine Bene, PharmD, Herve avet-Loiseau, MD, Thomas Dejoie, PharmD, Michel Attal
Journal: Blood
Blood (2016) 128 (22): 674.
https://doi.org/10.1182/blood.V128.22.674.674
Published: 2016
Journal Articles

Free Light Chain Escape in Multiple Myeloma : an Exceptional Phenomenon

Helene Caillon, PharmD, Michel Attal, Herve Avet-Loiseau, MD PhD, Cyrille Touzeau, MD, Philippe Moreau, Thomas Dejoie, PharmD
Journal: Blood
Blood (2016) 128 (22): 4428.
https://doi.org/10.1182/blood.V128.22.4428.4428
Published: 2016
Journal Articles

VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial

Clinical Trials & Observations
Philippe Moreau, Cyrille Hulin, Margaret Macro, Denis Caillot, Carine Chaleteix, Murielle Roussel, Laurent Garderet, Bruno Royer, Sabine Brechignac, Mourad Tiab, Mathieu Puyade, Martine Escoffre, Anne-Marie Stoppa, Thierry Facon, Brigitte Pegourie, Driss Chaoui, Arnaud Jaccard, Borhane Slama, Gerald Marit, Karim Laribi, Pascal Godmer, Odile Luycx, Jean-Claude Eisenmann, Olivier Allangba, Mamoun Dib, Carla Araujo, Jean Fontan, Karim Belhadj, Marc Wetterwald, Véronique Dorvaux, Jean-Paul Fermand, Philippe Rodon, Brigitte Kolb, Sylvie Glaisner, Jean-Valere Malfuson, Pascal Lenain, Laetitia Biron, Lucie Planche, Helene Caillon, Herve Avet-Loiseau, Thomas Dejoie, Michel Attal
Journal: Blood
Blood (2016) 127 (21): 2569–2574.
https://doi.org/10.1182/blood-2016-01-693580
Published: 2016
Journal Articles

Bortezomib, Thalidomide and Dexamethasone (VTD) Is Superior to Bortezomib, Cyclophosphamide and Dexamethasone (VCD) Prior to Autologous Stem Cell Transplantation for Patients with De Novo Multiple Myeloma. Results of the Prospective IFM 2013-04 Trial

Philippe Moreau, Cyrille Hulin, Margaret MACRO, MD, Denis Caillot, Carine Chaleteix, Murielle Roussel, Laurent Garderet, MD, Bruno Royer, MD, Sabine Brechignac, MD, Mourad Tiab, MD, Mathieu Puyade, MD, Martine Escoffre, Anne-Marie Stoppa, MD, Thierry Facon, Brigitte Pégourie, Driss Chaoui, MD, Arnaud Jaccard, MD PhD, Borhane Slama, Gerald Marit, Kamel Laribi, Pascal Godmer, MD, Odile Luycx, Jean Claude Eisenmann, MD, Olivier Allangha, Sylvie Glaisner, Mamoun Dib, Carla Araujo, Jean Fontan, Karim Belhadj, MD, Marc Wetterwald, MD PhD, Veronique Dorvaux, Jean-Paul Fermand, Philippe Rodon, MD, Brigitte Kolb, Pascal Lenain, MD, Lucie Planche, Laetitia Biron, Helene Caillon, Herve Avet-Loiseau, Thomas Dejoie, Michel Attal
Journal: Blood
Blood (2015) 126 (23): 393.
https://doi.org/10.1182/blood.V126.23.393.393
Published: 2015
Journal Articles

Multiple Myeloma (MM): Impact of Immunoglobulin Isotype on the Speed of Response

Helene Caillon, Michel Attal, Philippe Moreau, MD PhD, Thomas Dejoie
Journal: Blood
Blood (2015) 126 (23): 4191.
https://doi.org/10.1182/blood.V126.23.4191.4191
Published: 2015
Journal Articles

Comparing the Performance of Serum Free Light Chain Measurements with Urine Electrophoresis and Immunofixation for Monitoring and Assessing Response to Therapy in Patients with Multiple Myeloma

Thomas Dejoie, Michel Attal, Philippe Moreau, MD, Jean-Luc Harousseau, Herve Avet-Loiseau
Journal: Blood
Blood (2014) 124 (21): 3347.
https://doi.org/10.1182/blood.V124.21.3347.3347
Published: 2014
Journal Articles

Serum Free Light Chains Should be the Target of Response Evaluation in Light Chain Multiple Myeloma Rather Than Urines: Results from the IFM/DFCI 2009 Trial

Jill Corre, PharmD, PhD, Thomas Dejoie, PharmD, Helene Caillon, PharmD, Michel Attal, MD, Herve Avet-Loiseau, Philippe Moreau, MD
Journal: Blood
Blood (2014) 124 (21): 180.
https://doi.org/10.1182/blood.V124.21.180.180
Published: 2014